Triggering with GnRH agonist in oocyte-donation cycles: oestradiol monitoring is not necessary during ovarian stimulation

Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles

Evangelos Papanikolaou, Cristina Pozzobon, Efstratios M. Κolibianakis et al. · Fertility and Sterility · 2006 · 340 citations · Full text

Medicine, Endocrinology, Gynecology +13

Endometrial thickness and serum oestradiol concentrations as predictors of outcome in oocyte donation

J. Remohı́, Gerardo Ardiles, Juan A. García-Velasco et al. · Human Reproduction · 1997 · 180 citations · Full text

Medicine, Gynecology, Obstetrics +10

Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates

Belen Acevedo, José Luis Gómez-Palomares, Elisabetta Ricciarelli et al. · Fertility and Sterility · 2006 · 147 citations · Full text

Medicine, Gynecology, Obstetrics +14

GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study

María Melo, CE Busso, José Bellver et al. · Reproductive BioMedicine Online · 2009 · 127 citations · Full text

Medicine, Endocrinology, Gynecology +13

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study

Daniel Bodri, Juan José Guillén, Anna Galindo et al. · Fertility and Sterility · 2008 · 123 citations · Full text

Veterinary Medicine, Gynecology, Obstetrics +16